Cough-Cold and Flu

PALATINE, Ill. — Acura Pharmaceuticals on Monday reported the completed transition of Nexafed and Nexafed Sinus to MainPointe Pharmaceuticals as that company commences selling activities with a new formulation coming to market soon.

WAUKESHA, Wis. — Cold and allergy is the leading front-of-store category as measured by dollar sales for independents, Hamacher Resource Group reported in a blog on Monday. All told, the category represents 17.9% of all health, beauty and wellness sales.

That total is slightly down, 0.6%, from last year’s percentage, but HRG is confident cough cold sales will swing up in the coming season.

ARLINGTON, Va. — Making influenza immunizations available through retail pharmacy increases the odds that a patient will get the flu shot, according to an article published in Clinical Therapeutics last week.

The research cited by Clinical Therapeutics was conducted by Avalere and the National Association of Chain Drug Stores.

DUBLIN — As more consumers continue to capitalize on the value of a national brand equivalent through the appeal of the kind of own brand mindset many retailers have today, private label has never looked so promising. Not only is there continued growth in core categories due to the migration of consumers from national brand to store brand, but also the potential for new OTC product classes to emerge as the administration struggles to make healthcare more affordable.

GRAND RAPIDS, Mich. — Meijer pharmacies across the Midwest are holding Back to School Immunization Events this weekend to help families guard against the flu before classes start.

GRAND RAPIDS, Mich. — Meijer and Spectrum Health today announced they have collaborated to launch a line of co-branded over-the-counter products.

“As the nation’s ninth largest grocery retailer, Meijer has an undeniable presence throughout the Midwest,” Spectrum Health SVP and chief strategy officer Roger Jansen said. “We are excited to work with Meijer. This collaboration enables Spectrum Health to meet consumers where they are on their health-and-wellness journey.”

There’s a global race right now to become the global drug chain leader. It brings three very different things together: the board game Risk, an iceberg and a Bob Dylan song. I’ll explain.